Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00207584
Other study ID # CDC-NCHSTP-9997
Secondary ID
Status Completed
Phase N/A
First received September 13, 2005
Last updated September 13, 2005
Start date January 1994
Est. completion date April 1994

Study information

Verified date September 2005
Source Centers for Disease Control and Prevention
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

This study was designed to determine whether taking daily doxycycline during an outbreak of Mycoplasma pneumoniae could prevent a person from getting infected and interrupt ongoing disease transmission during an outbreak. Doxycycline is a treatment for Mycoplasma pneumoniae, but it is not certain that the drug could prevent disease if used prophylactically.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date April 1994
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Working at hospital facility where outbreak of Mycoplasma pneumoniae occured

Exclusion Criteria:

- Pregnant, on antiseizure medications, allergic to macrolide antibiotics

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind


Intervention

Drug:
Doxycycline treatment


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centers for Disease Control and Prevention
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06325293 - A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study N/A
Completed NCT02511262 - Detection of Mycoplasma Pneumoniae N/A